Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib-Reference-Cited by-同舟云学术

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib

Published:2017-03 Issue: Volume:88 Page:15-20
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Nishino Mizuki,Sacher Adrian G.,Gandhi Leena,Chen Zhao,Akbay Esra,Fedorov Andriy,Westin Carl F.,Hatabu Hiroto,Johnson Bruce E.,Hammerman Peter,Wong Kwok-kin

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference21 articles.

1. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response;Chen;Nature,2012

2. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat. Rev. Cancer,2014

3. Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance;Chen;Clin. Cancer Res.,2014

4. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies;Ji;Cancer Cell,2006

5. Reporting results of cancer treatment;Miller;Cancer,1981

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mmp12 Is Upregulated by in utero Second-Hand Smoke Exposures and Is a Key Factor Contributing to Aggravated Lung Responses in Adult Emphysema, Asthma, and Lung Cancer Mouse Models;Frontiers in Physiology;2021-11-29

2. Detection of Lung Nodules in Micro-CT Imaging Using Deep Learning;Tomography;2021-08-07

3. Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2021-07-30

4. Deep Learning Segmentation of Triple-Negative Breast Cancer (TNBC) Patient Derived Tumor Xenograft (PDX) and Sensitivity of Radiomic Pipeline to Tumor Probability Boundary;Cancers;2021-07-28

5. Co-clinical FDG-PET Radiomic Signature in Predicting Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer;2021-06-12